Silverbirch Healthcare Ltd 10891819 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is healthcare and related services. Digita Accounts Production Advanced 6.30.9574.0 true 10891819 2024-11-01 2025-10-31 10891819 2025-10-31 10891819 bus:Director1 1 2025-10-31 10891819 bus:OrdinaryShareClass1 2025-10-31 10891819 core:RetainedEarningsAccumulatedLosses 2025-10-31 10891819 core:ShareCapital 2025-10-31 10891819 core:CurrentFinancialInstruments 2025-10-31 10891819 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 10891819 core:Non-currentFinancialInstruments 2025-10-31 10891819 core:Non-currentFinancialInstruments core:AfterOneYear 2025-10-31 10891819 core:FurnitureFittingsToolsEquipment 2025-10-31 10891819 bus:SmallEntities 2024-11-01 2025-10-31 10891819 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 10891819 bus:FullAccounts 2024-11-01 2025-10-31 10891819 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 10891819 bus:RegisteredOffice 2024-11-01 2025-10-31 10891819 bus:Director1 2024-11-01 2025-10-31 10891819 bus:Director1 1 2024-11-01 2025-10-31 10891819 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 10891819 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 10891819 bus:Agent1 2024-11-01 2025-10-31 10891819 core:RetainedEarningsAccumulatedLosses 2024-11-01 2025-10-31 10891819 core:ShareCapital 2024-11-01 2025-10-31 10891819 core:FurnitureFittings 2024-11-01 2025-10-31 10891819 core:FurnitureFittingsToolsEquipment 2024-11-01 2025-10-31 10891819 core:OfficeEquipment 2024-11-01 2025-10-31 10891819 countries:AllCountries 2024-11-01 2025-10-31 10891819 2024-10-31 10891819 bus:Director1 1 2024-10-31 10891819 core:RetainedEarningsAccumulatedLosses 2024-10-31 10891819 core:ShareCapital 2024-10-31 10891819 core:FurnitureFittingsToolsEquipment 2024-10-31 10891819 2023-11-01 2024-10-31 10891819 2024-10-31 10891819 bus:Director1 1 2024-10-31 10891819 bus:OrdinaryShareClass1 2024-10-31 10891819 core:CurrentFinancialInstruments 2024-10-31 10891819 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 10891819 core:Non-currentFinancialInstruments 2024-10-31 10891819 core:Non-currentFinancialInstruments core:AfterOneYear 2024-10-31 10891819 core:FurnitureFittingsToolsEquipment 2024-10-31 10891819 bus:Director1 2023-11-01 2024-10-31 10891819 bus:Director1 1 2023-11-01 2024-10-31 10891819 core:RetainedEarningsAccumulatedLosses 2023-11-01 2024-10-31 10891819 core:ShareCapital 2023-11-01 2024-10-31 10891819 2023-10-31 10891819 bus:Director1 1 2023-10-31 10891819 core:RetainedEarningsAccumulatedLosses 2023-10-31 10891819 core:ShareCapital 2023-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10891819

Silverbirch Healthcare Ltd
Annual Report and Unaudited Financial Statements
for the Year Ended 31 October 2025

Silverbirch Healthcare Ltd

Contents

Company Information | 1
Director's Report | 2
Accountants' Report | 3
Profit and Loss Account | 4
Statement of Comprehensive Income | 5
Balance Sheet | 6
Statement of Changes in Equity | 7
Notes to the Unaudited Financial Statements | 8 to 14

Silverbirch Healthcare Ltd

Company Information

Director | Catherine Cleary

Registered office | 17 Highfield Road Dartford Dartford England DA1 2JS

Accountants | Krystal Clear Accounting Westgate House 44 Hale Road Ground Floor Hale, Altrincham Cheshire WA14 2EX

Silverbirch Healthcare Ltd

Director's Report for the Year Ended 31 October 2025

The director presents her report and the financial statements for the year ended 31 October 2025.

Director of the company

The director who held office during the year was as follows:

Catherine Cleary

Principal activity

The principal activity of the company is healthcare and related services.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 28 July 2026

......................................... Catherine Cleary Director

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Silverbirch Healthcare Ltd
for the Year Ended 31 October 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Silverbirch Healthcare Ltd for the year ended 31 October 2025 as set out on pages 4 to 14 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Chartered Institute of Management Accountants, we are subject to its ethical and other professional requirements.

This report is made solely to the Board of Directors of Silverbirch Healthcare Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Silverbirch Healthcare Ltd and state those matters that we have agreed to state to the Board of Directors of Silverbirch Healthcare Ltd. To the fullest by law, we do not accept or assume responsibility to anyone other than and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Silverbirch Healthcare Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Silverbirch Healthcare Ltd. You consider that Silverbirch Healthcare Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Silverbirch Healthcare Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
Krystal Clear Accounting
Westgate House
44 Hale Road
Ground Floor
Hale, Altrincham
Cheshire
WA14 2EX

28 July 2026

Silverbirch Healthcare Ltd

Profit and Loss Account for the Year Ended 31 October 2025

| Note | 2025 £ | 2024 £
Turnover |  | 982,122 | 1,165,006
Cost of sales |  | (861,417) | (978,094)
Gross profit |  | 120,705 | 186,912
Administrative expenses |  | (213,258) | (213,766)
Operating loss |  | (92,553) | (26,854)
Interest payable and similar expenses |  | (1,518) | -
Loss before tax | 4 | (94,071) | (26,854)
Loss for the financial year |  | (94,071) | (26,854)

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

Silverbirch Healthcare Ltd

Statement of Comprehensive Income for the Year Ended 31 October 2025

| 2025 £ | 2024 £
Loss for the year | (94,071) | (26,854)
Total comprehensive income for the year | (94,071) | (26,854)

Silverbirch Healthcare Ltd

(Registration number: 10891819)
Balance Sheet as at 31 October 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 5 | 1,799 | 3,117
Current assets |  |  |
Debtors | 6 | 99,557 | 119,615
Cash at bank and in hand |  | 4,144 | -
|  | 103,701 | 119,615
Creditors: Amounts falling due within one year | 7 | (334,893) | (253,355)
Net current liabilities |  | (231,192) | (133,740)
Total assets less current liabilities |  | (229,393) | (130,623)
Creditors: Amounts falling due after more than one year | 7 | (20,533) | (25,232)
Net liabilities |  | (249,926) | (155,855)
Capital and reserves |  |  |
Called up share capital | 8 | 100 | 100
Retained earnings |  | (250,026) | (155,955)
Shareholders' deficit |  | (249,926) | (155,855)

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the director on 28 July 2026

......................................... Catherine Cleary Director

Silverbirch Healthcare Ltd

Statement of Changes in Equity for the Year Ended 31 October 2025

| Share capital £ | Retained earnings £ | Total £
At 1 November 2024 | 100 | (155,955) | (155,855)
Loss for the year | - | (94,071) | (94,071)
At 31 October 2025 | 100 | (250,026) | (249,926)

| Share capital £ | Retained earnings £ | Total £
At 1 November 2023 | 100 | (129,101) | (129,001)
Loss for the year | - | (26,854) | (26,854)
At 31 October 2024 | 100 | (155,955) | (155,855)

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

1 | General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
17 Highfield Road
Dartford
Dartford
DA1 2JS
England

These financial statements were authorised for issue by the director on 28 July 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office equipment | 20% Straight line
Furnture and fittings | 33% Reducing balance

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 60 (2024 - 60).

4 | Loss before tax

Arrived at after charging/(crediting)

| 2025 £ | 2024 £
Depreciation expense | 1,320 | 1,889

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

5 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 November 2024 | 24,200 | 24,200
At 31 October 2025 | 24,200 | 24,200
Depreciation
At 1 November 2024 | 21,082 | 21,082
Charge for the year | 1,319 | 1,319
At 31 October 2025 | 22,401 | 22,401
Carrying amount
At 31 October 2025 | 1,799 | 1,799
At 31 October 2024 | 3,117 | 3,117

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 38,240 | 15,431
Other debtors | 61,317 | 104,184
| 99,557 | 119,615

7 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 9 | 23,573 | 14,092
Taxation and social security |  | 242,196 | 147,236
Accruals and deferred income |  | 48,491 | 59,590
Other creditors |  | 20,633 | 32,437
|  | 334,893 | 253,355

Creditors: amounts falling due after more than one year

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 9 | 20,533 | 25,232

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £1 each | 100 | 100 | 100 | 100

9 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Other borrowings | 20,533 | 25,232

Current loans and borrowings

| 2025 £ | 2024 £
Bank overdrafts | 15,099 | 5,988
Other borrowings | 8,474 | 8,104
| 23,573 | 14,092

10 | Related party transactions

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Transactions with the director

2025 | At 1 November 2024 £ | Repayments by director £ | At 31 October 2025 £
Catherine Cleary
Loan | (1,888) | (370) | (2,258)

2024 | At 1 November 2023 £ | Repayments by director £ | At 31 October 2024 £
Catherine Cleary
Loan | (20,280) | 18,392 | (1,888)

Silverbirch Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Director's remuneration

The director's remuneration for the year was as follows:

| 2025 £ | 2024 £
Remuneration | 60,782 | 48,513